13F-HR filed by Monashee Investment Management LLC
Monashee Investment Management LLC filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-12, with 44 holding rows worth $566,544,893.
- Accession
- 0001172661-24-000711
- Filer
- CIK 1627608
- Filed
- 2024-02-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 44 entries on the cover page, a total value of $566,544,893 stated on the cover page (in dollars after the unit check, H1), rows summing to $566,544,893 with VALUE read as dollars as filed, 13F file number 028-16854. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ISHARES TR CORE S&P 500 ETF | 464287200 | SHS | 248,710 | $118,791,357 | dollars as filed | |
| Vanguard S&P 500 ETF | 922908363 | COM | 271,010 | $118,377,168 | dollars as filed | |
| Vanguard FTSE Developed Markets ETF | 921943858 | SHS | 1,549,700 | $74,230,630 | dollars as filed | |
| iShares Core MSCI EAFE ETF | 46432F842 | SHS | 782,380 | $55,040,433 | dollars as filed | |
| VWO | 922042858 | SHS | 942,960 | $38,755,656 | dollars as filed | |
| iShares Core MSCI Emerging Markets ETF | 46434G103 | SHS | 660,700 | $33,418,206 | dollars as filed | |
| iShares Core S&P Total U.S. Stock Market ETF | 464287150 | SHS | 216,860 | $22,820,178 | dollars as filed | |
| VTI | 922908769 | COM | 96,060 | $22,787,353 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 191,855 | $7,820,010 | dollars as filed | |
| AERCAP HOLDINGS NV SHS | N00985106 | Stock | 90,000 | $6,688,800 | dollars as filed | |
| PG&E CORP COM | 69331C108 | Stock | 260,000 | $4,687,800 | dollars as filed | |
| KORRO BIO INC | 500946108 | COMMON STOCK | 90,805 | $4,352,284 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 175,000 | $4,044,250 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 100,209 | $3,974,289 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 350,000 | $3,930,500 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 10,000 | $3,804,300 | dollars as filed | |
| LAS VEGAS SANDS CORP COM | 517834107 | Stock | 75,000 | $3,690,750 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 3,459,854 | $3,157,117 | dollars as filed | |
| AMBRX BIOPHARMA INC | 641871108 | COM | 207,500 | $2,954,800 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 70,000 | $2,949,100 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 73,949 | $2,699,139 | dollars as filed | |
| PERMIAN RESOURCES CORP CLASS A COM | 71424F105 | Stock | 175,900 | $2,392,240 | dollars as filed | |
| FLUENCE ENERGY INC | 34379V103 | COM CL A | 100,000 | $2,385,000 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 37,500 | $2,355,000 | dollars as filed | |
| VESTA REAL ESTATE CORP | 92540K109 | ADS | 55,000 | $2,179,100 | dollars as filed | |
| KINETIK HOLDINGS INC COM NEW CL A | 02215L209 | Stock | 64,900 | $2,167,660 | dollars as filed | |
| KLAVIYO INC COM SER A | 49845K101 | Stock | 68,974 | $1,916,098 | dollars as filed | |
| AURA BIOSCIENCES INC | 05153U107 | COMMON STOCK | 198,415 | $1,757,957 | dollars as filed | |
| HCI GROUP INC | 40416E103 | COM | 19,790 | $1,729,646 | dollars as filed | |
| COREBRIDGE FINL INC COM | 21871X109 | Stock | 75,000 | $1,624,500 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 140,000 | $1,563,800 | dollars as filed | |
| RUNWAY GROWTH FINANCE CORP | 78163D100 | COM | 91,739 | $1,157,746 | dollars as filed | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 74,792 | $964,103 | dollars as filed | |
| MYRIAD GENETICS INC | 62855J104 | COM | 50,000 | $957,000 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 500,000 | $780,000 | dollars as filed | |
| SHATTUCK LABS INC | 82024L103 | COMMON STOCK | 100,000 | $713,000 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 33,997 | $696,599 | dollars as filed | |
| BLUEBIRD BIO INC | 09609G100 | COM | 500,000 | $690,000 | dollars as filed | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 103,300 | $521,665 | dollars as filed | |
| MOLECULAR TEMPLATES INC | 608550208 | COM | 121,841 | $454,467 | dollars as filed | |
| CIDARA THERAPEUTICS INC COM NEW | 171757107 | Stock | 369,099 | $293,065 | dollars as filed | |
| Vivid Seats Inc | 92854T100 | Common Stock | 30,000 | $189,600 | dollars as filed | |
| PURECYCLE TECHNOLOGIES INC | 74623V103 | COM | 11,754 | $47,604 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 132,435 | $34,923 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-24-000711 | this filing | 2024-02-12 | acceptance time not in the bulk data set |